ORIC
Price
$9.90
Change
+$1.30 (+15.12%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
699.32M
69 days until earnings call
SVRA
Price
$2.73
Change
-$0.07 (-2.51%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
466.8M
57 days until earnings call
Ad is loading...

ORIC vs SVRA

Header iconORIC vs SVRA Comparison
Open Charts ORIC vs SVRABanner chart's image
Oric Pharmaceuticals
Price$9.90
Change+$1.30 (+15.12%)
Volume$14.32K
Capitalization699.32M
Savara
Price$2.73
Change-$0.07 (-2.51%)
Volume$18.91K
Capitalization466.8M
ORIC vs SVRA Comparison Chart
Loading...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORIC vs. SVRA commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORIC is a StrongBuy and SVRA is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (ORIC: $9.91 vs. SVRA: $2.72)
Brand notoriety: ORIC and SVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORIC: 277% vs. SVRA: 109%
Market capitalization -- ORIC: $699.32M vs. SVRA: $466.8M
ORIC [@Biotechnology] is valued at $699.32M. SVRA’s [@Biotechnology] market capitalization is $466.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $374.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORIC’s FA Score shows that 1 FA rating(s) are green whileSVRA’s FA Score has 0 green FA rating(s).

  • ORIC’s FA Score: 1 green, 4 red.
  • SVRA’s FA Score: 0 green, 5 red.
According to our system of comparison, ORIC is a better buy in the long-term than SVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORIC’s TA Score shows that 4 TA indicator(s) are bullish while SVRA’s TA Score has 3 bullish TA indicator(s).

  • ORIC’s TA Score: 4 bullish, 5 bearish.
  • SVRA’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, SVRA is a better buy in the short-term than ORIC.

Price Growth

ORIC (@Biotechnology) experienced а +7.48% price change this week, while SVRA (@Biotechnology) price change was -10.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.85%. For the same industry, the average monthly price growth was -2.06%, and the average quarterly price growth was -3.70%.

Reported Earning Dates

ORIC is expected to report earnings on May 12, 2025.

SVRA is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-6.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORIC($699M) has a higher market cap than SVRA($467M). ORIC YTD gains are higher at: 22.800 vs. SVRA (-11.401). SVRA has higher annual earnings (EBITDA): -88.58M vs. ORIC (-133.69M). ORIC has more cash in the bank: 272M vs. SVRA (219M). ORIC has less debt than SVRA: ORIC (3.12M) vs SVRA (26.7M). ORIC (0) and SVRA (0) have equivalent revenues.
ORICSVRAORIC / SVRA
Capitalization699M467M150%
EBITDA-133.69M-88.58M151%
Gain YTD22.800-11.401-200%
P/E RatioN/AN/A-
Revenue00-
Total Cash272M219M124%
Total Debt3.12M26.7M12%
FUNDAMENTALS RATINGS
SVRA: Fundamental Ratings
SVRA
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
66
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ORICSVRA
RSI
ODDS (%)
Bullish Trend 7 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
78%
Momentum
ODDS (%)
Bullish Trend 7 days ago
82%
Bearish Trend 7 days ago
82%
MACD
ODDS (%)
Bullish Trend 7 days ago
69%
Bearish Trend 7 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
85%
Bearish Trend 7 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 7 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 26 days ago
80%
Declines
ODDS (%)
Bearish Trend 15 days ago
87%
Bearish Trend 15 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
88%
Bullish Trend 7 days ago
74%
Aroon
ODDS (%)
Bearish Trend 7 days ago
89%
N/A
View a ticker or compare two or three
Ad is loading...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSMVX27.720.29
+1.06%
Transamerica Small/Mid Cap Value I2
HNLVX21.480.20
+0.94%
Harbor Large Cap Value Retirement
NBNGX24.480.20
+0.82%
Sit Mid Cap Growth
LIFEX15.950.12
+0.76%
Domini Sustainable Solutions Ins
VPACX13.400.04
+0.30%
Vanguard Pacific Stock Index Investor

ORIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with KYMR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
+15.23%
KYMR - ORIC
46%
Loosely correlated
+7.79%
ACLX - ORIC
42%
Loosely correlated
-4.02%
BPMC - ORIC
42%
Loosely correlated
-0.77%
ATXS - ORIC
41%
Loosely correlated
-1.21%
IMNM - ORIC
41%
Loosely correlated
-6.57%
More

SVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with KYMR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
-2.51%
KYMR - SVRA
43%
Loosely correlated
+7.79%
LRMR - SVRA
42%
Loosely correlated
-5.46%
PLRX - SVRA
39%
Loosely correlated
-4.50%
ABSI - SVRA
38%
Loosely correlated
-4.91%
ATXS - SVRA
38%
Loosely correlated
-1.21%
More